Structure of the C-terminal domains of merozoite surface protein-1 from Plasmodium knowlesi reveals a novel histidine binding site

被引:33
作者
Garman, SC
Simcoke, WN
Stowers, AW
Garboczi, DN
机构
[1] NIAID, Immunogenet Lab, Struct Biol Sect, NIH, Rockville, MD 20852 USA
[2] NIAID, Malaria Vaccine Dev Unit, Parasit Dis Lab, NIH, Rockville, MD 20852 USA
关键词
D O I
10.1074/jbc.M210716200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protozoan parasite Plasmodium causes malaria, with hundreds of millions of cases recorded annually. Protection against malaria infection can be conferred by antibodies against merozoite surface protein (MSP)-1, making it an attractive vaccine candidate. Here we present the structure of the C-terminal domains of MSP-1 (known as MSP-1,9) from Plasmodium knowlesi. The structure reveals two tightly packed epidermal growth factor-like domains oriented head to tail. In domain 1, the molecule displays a histidine binding site formed primarily by a highly conserved tryptophan. The protein carries a pronounced overall negative charge primarily due to the large number of acidic groups in domain 2. To map protein binding surfaces on MSP-1(19), we have analyzed the crystal contacts in five different crystal environments, revealing that domain 1 is highly preferred in protein-protein interactions. A comparison of MSP-1(19), structures from P. knowlesi, P. cynomolgi, and P. falciparum shows that, although the overall protein folds are similar, the molecules show significant differences in charge distribution. We propose the histidine binding site in domain 1 as a target for inhibitors of protein binding to MSP-1, which might prevent invasion of the merozoite into red blood cells.
引用
收藏
页码:7264 / 7269
页数:6
相关论文
共 46 条
  • [1] Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity
    AlYaman, F
    Genton, B
    Kramer, KJ
    Chang, SP
    Hui, GS
    Baisor, M
    Alpers, MP
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 54 (05) : 443 - 448
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [5] PROTEOLYTIC PROCESSING OF THE PLASMODIUM-FALCIPARUM MEROZOITE SURFACE PROTEIN-1 PRODUCES A MEMBRANE-BOUND FRAGMENT CONTAINING 2 EPIDERMAL GROWTH FACTOR-LIKE DOMAINS
    BLACKMAN, MJ
    LING, IT
    NICHOLLS, SC
    HOLDER, AA
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1991, 49 (01) : 29 - 34
  • [6] PROCESSING OF THE PLASMODIUM-FALCIPARUM MAJOR MEROZOITE SURFACE PROTEIN-1 - IDENTIFICATION OF A 33-KILODALTON SECONDARY PROCESSING PRODUCT WHICH IS SHED PRIOR TO ERYTHROCYTE INVASION
    BLACKMAN, MJ
    WHITTLE, H
    HOLDER, AA
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1991, 49 (01) : 35 - 44
  • [7] A SINGLE FRAGMENT OF A MALARIA MEROZOITE SURFACE PROTEIN REMAINS ON THE PARASITE DURING RED-CELL INVASION AND IS THE TARGET OF INVASION-INHIBITING ANTIBODIES
    BLACKMAN, MJ
    HEIDRICH, HG
    DONACHIE, S
    MCBRIDE, JS
    HOLDER, AA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) : 379 - 382
  • [8] ANTIBODIES INHIBIT THE PROTEASE-MEDIATED PROCESSING OF A MALARIA MEROZOITE SURFACE PROTEIN
    BLACKMAN, MJ
    SCOTTFINNIGAN, TJ
    SHAI, S
    HOLDER, AA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) : 389 - 393
  • [9] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [10] CHANG SP, 1992, J IMMUNOL, V149, P548